• Genmab A/ S sharpened by antibody partnerships as oncology pipeline expands ad-hoc-news.de Thu, 09 Jul 2026 10:49:11 GMT
• Is Genmab A/S (GMAB) Stock Undervalued After Positive Epkinly DLBCL Trial Results? Yahoo Finance Wed, 08 Jul 2026 15:04:48 GMT
• Genmab advances antibody portfolio as oncology partnerships deepen ad-hoc-news.de Wed, 08 Jul 2026 14:37:08 GMT
• Genmab A/ S expands antibody reach as oncology pipeline matures ad-hoc-news.de Tue, 07 Jul 2026 13:14:07 GMT
• Genmab rebounds on a European Commission decision marketscreener.com Tue, 07 Jul 2026 07:52:22 GMT
• Genmab A/ S strategy underpins long-term growth prospects ad-hoc-news.de Tue, 07 Jul 2026 07:08:27 GMT
• Genmab Announces TEPKINLY® (epcoritamab) in Combination with Lenalidomide and Rituximab is Approved by the European Commission for... Business Wire Mon, 06 Jul 2026 17:45:00 GMT
• Genmab Announces Tepkinly in Combination with Lenalidomide and Rituximab Is Approved by the European Commission for the Treatment ... marketscreener.com Mon, 06 Jul 2026 17:45:00 GMT
• BNP Paribas raises the target price for Genmab to 2,500 Danish kroner (2,400), reiterates outperform - BN marketscreener.com Mon, 06 Jul 2026 13:38:22 GMT
• Genmab A/ S highlights antibody oncology platform as US partnerships deepen ad-hoc-news.de Mon, 06 Jul 2026 11:23:54 GMT
• genmab q1 2026 slides: 25% revenue growth, $5b+ pipeline potential Investing.com Sun, 05 Jul 2026 19:10:34 GMT
• genmab q1 2026 slides: 25% revenue growth, $5b+ pipeline potential Investing.com Sat, 04 Jul 2026 11:08:33 GMT
• Genmab A/ S strengthens its antibody portfolio as oncology partnerships expand ad-hoc-news.de Sat, 04 Jul 2026 06:10:09 GMT
• genmab outlines growth ambitions as antibody pipeline expands AD HOC NEWS Thu, 02 Jul 2026 21:47:43 GMT
• H.C. Wainwright raises Genmab stock price target on trial success Investing.com Thu, 02 Jul 2026 11:40:24 GMT
• genmab a/s highlights antibody oncology portfolio as global demand for targeted therapies expands AD HOC NEWS Wed, 01 Jul 2026 16:36:22 GMT
• Genmab/AbbVie Lymphoma Trial Meets Main Goal, Analyst Eyes Bigger Market Opportunity Sahm Wed, 01 Jul 2026 13:58:57 GMT
• genmab/abbvie lymphoma trial meets main goal, analyst eyes bigger market opportunity Benzinga Tue, 30 Jun 2026 16:31:46 GMT
• Genmab stock rises on positive lymphoma trial results By Investing.com Investing.com Nigeria Mon, 29 Jun 2026 23:01:47 GMT
• Genmab Announces Positive Phase 3 Results for Epcoritamab Plus Lenalidomide in Patients with Relapsed/Refractory Diffuse Large B-C... GlobeNewswire Mon, 29 Jun 2026 20:14:00 GMT
• Genmab A/S (GMAB) Investor Outlook: Exploring a 40.96% Potential Upside in the Biotech Sector DirectorsTalk Interviews Mon, 29 Jun 2026 09:15:35 GMT
• Genmab (GMAB) Phase 3 epcoritamab combo cuts DLBCL progression risk Stock Titan Mon, 29 Jun 2026 07:00:00 GMT
• Genmab reports positive phase 3 trial results for lymphoma drug Investing.com Mon, 29 Jun 2026 07:00:00 GMT
• darzalex from genmab a/ s - subcutaneous dosing reshapes myeloma care Ad-hoc-news.de Sun, 28 Jun 2026 03:11:12 GMT
• gmab stock news today | earnings, events & price alerts Intellectia AI Sat, 27 Jun 2026 15:00:10 GMT
• genmab opens the weekend with a clear strategy focus, shares hold their biotech range Ad-hoc-news.de Sat, 27 Jun 2026 12:43:28 GMT
• Genmab A/S Sponsored ADR Actuals & Estimates (NASDAQ:GMAB) TradingView Sat, 27 Jun 2026 04:13:26 GMT
• Avoiding Lag: Real-Time Signals in (GMAB) Movement Stock Traders Daily Fri, 26 Jun 2026 17:10:02 GMT
• genmab capital increase from employee warrants, shares remain active on nasdaq Ad-hoc-news.de Fri, 26 Jun 2026 13:45:26 GMT
• Genmab A/S Stock 12‑Month Price Target Raised to $37.21, Implies 42% Upside TradingView Fri, 26 Jun 2026 05:20:00 GMT
• genmab a/s (gmab) valuation: pe, pb & fair value analysis TradingKey Thu, 25 Jun 2026 07:00:00 GMT
• genmab a/s (gmab) technical analysis: support, resistance, indicators & moving averages TradingKey Thu, 25 Jun 2026 07:00:00 GMT
• genmab lands hc wainwright buy reiteration, shares trade near nasdaq range Ad-hoc-news.de Wed, 24 Jun 2026 07:18:22 GMT
• genmab a/s (gmab) financial health: profitability & balance sheet analysis TradingKey Wed, 24 Jun 2026 07:00:00 GMT
• genmab a/s (gmab) risk assessment: volatility, financial risk & investment risk TradingKey Wed, 24 Jun 2026 07:00:00 GMT
• alphavalue/baader europe reduces eps estimates for genmab on merger financing costs marketscreener.com Wed, 24 Jun 2026 04:03:31 GMT
• genmab a/s (gmab) valuation: pe, pb & fair value analysis TradingKey Tue, 23 Jun 2026 07:11:03 GMT
• genmab: financing weighs now, pipeline pays later marketscreener.com Tue, 23 Jun 2026 07:00:00 GMT
• genmab a/s (gmab) stock analysis: biotechnology giant displays 45.7% potential upside DirectorsTalk Interviews Mon, 22 Jun 2026 09:15:52 GMT
• genmab stock - analyst consensus and growth expectations AD HOC NEWS Mon, 22 Jun 2026 02:22:56 GMT
• genmab a/s (gmab) earnings forecast: future eps & revenue growth estimates TradingKey Sat, 20 Jun 2026 08:11:38 GMT
• Genmab A/S (GMAB) Technical Analysis: Support, Resistance, Indicators & Moving Averages TradingKey Sat, 20 Jun 2026 07:40:15 GMT
• genmab a/s (gmab) shareholder structure: major shareholders & institutional holdings TradingKey Fri, 19 Jun 2026 22:10:45 GMT
• genmab stock - new employee rsus and warrants while sector re-rates AD HOC NEWS Fri, 19 Jun 2026 11:26:58 GMT
• Genmab A/S (GMAB) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution TradingKey Fri, 19 Jun 2026 04:40:18 GMT
• genmab updates articles of association, extends capital-raising powers The Globe and Mail Thu, 18 Jun 2026 16:10:00 GMT
• genmab a/s (gmab) financial health: profitability & balance sheet analysis TradingKey Thu, 18 Jun 2026 07:00:00 GMT
• genmab a/s (gmab) technical analysis: support, resistance, indicators & moving averages TradingKey Thu, 18 Jun 2026 07:00:00 GMT
• genmab a/s (gmab) risk assessment: volatility, financial risk & investment risk TradingKey Thu, 18 Jun 2026 07:00:00 GMT
• genmab a/s (gmab) valuation: pe, pb & fair value analysis TradingKey Thu, 18 Jun 2026 07:00:00 GMT
• genmab announces minor capital increase following employee warrant exercise The Globe and Mail Wed, 17 Jun 2026 20:08:00 GMT
• genmab stock - minor capital increase after employee warrant exercise AD HOC NEWS Wed, 17 Jun 2026 16:11:08 GMT
• [6-K] GENMAB A/S Current Report (Foreign Issuer) | GMAB SEC Filing - Form 6-K Stock Titan Wed, 17 Jun 2026 07:00:00 GMT
• genmab a/s stock (dk0010272202): quarterly earnings frame the outlook for the nasdaq-listed biotech AD HOC NEWS Tue, 16 Jun 2026 18:35:08 GMT
• genmab discloses orbis as new 4.99% major shareholder The Globe and Mail Tue, 16 Jun 2026 16:40:00 GMT
• Capital Increase in Genmab as a Result of Employee Warrant Exercise Yahoo Finance Tue, 16 Jun 2026 07:00:00 GMT
• Genmab (NASDAQ: GMAB) issues 185 new shares from employee warrants Stock Titan Tue, 16 Jun 2026 07:00:00 GMT
• genmab updates articles of association to expand capital-raising flexibility The Globe and Mail Tue, 16 Jun 2026 07:00:00 GMT
• genmab a/s (gmab) stock analysis: unveiling a 46.80% potential upside in the biotech arena DirectorsTalk Interviews Mon, 15 Jun 2026 09:18:25 GMT
• orbis reduces genmab (gmab) stake to 4.99% of voting rights Stock Titan Mon, 15 Jun 2026 07:00:00 GMT
• genmab a/ s stock (dk0010272202): epcoritamab data keep oncology biotech in focus AD HOC NEWS Sun, 14 Jun 2026 18:48:23 GMT
• genmab a/s stock (dk0010272202): insider and ownership filings put the biotech in focus AD HOC NEWS Sat, 13 Jun 2026 20:16:59 GMT
• epcoritamab shows high response rates in elderly diffuse large b-cell lymphoma patients in new trials. Pluang Sat, 13 Jun 2026 19:28:49 GMT
• Genmab Announces Epcoritamab Monotherapy and Epcoritamab-Based Combination Regimens Demonstrate High Response Rates in Elderly Pat... Yahoo Finance UK Sat, 13 Jun 2026 07:00:00 GMT
• grant of restricted stock units and warrants to employees in genmab The Manila Times Fri, 12 Jun 2026 07:00:00 GMT
• genmab grants new restricted stock units and warrants to employees The Globe and Mail Fri, 12 Jun 2026 07:00:00 GMT
• Genmab (GMAB) awards new RSUs and warrants under long-term incentive plans Stock Titan Thu, 11 Jun 2026 07:00:00 GMT
• Genmab Presents EPCORE® FL-1 Subgroup Data Demonstrating Consistent Efficacy and Safety Results for Epcoritamab in Combination wit... GlobeNewswire Thu, 11 Jun 2026 07:00:00 GMT
• grant of restricted stock units and warrants to employees in genmab GlobeNewswire Thu, 11 Jun 2026 07:00:00 GMT
• genmab presents subgroup analysis data for follicular lymphoma Investing.com Thu, 11 Jun 2026 07:00:00 GMT
• Genmab A/S (GMAB) Stock Analysis: A 46% Upside Potential That Investors Can’t Ignore DirectorsTalk Interviews Mon, 08 Jun 2026 07:00:00 GMT
• is renewed analyst support reshaping genmab's (cpse:gmab) transition toward a commercial oncology powerhouse? simplywall.st Mon, 08 Jun 2026 07:00:00 GMT
• genmab a/s stock (dk0010272202): shares steady as investors digest q1 2026 update and valuation metr AD HOC NEWS Fri, 05 Jun 2026 19:31:35 GMT
• genmab a/s stock (dk0010272202): shares stabilize after recent volatility on nasdaq copenhagen AD HOC NEWS Thu, 04 Jun 2026 18:05:54 GMT
• genmab a/s stock (dk0010272202): shares trade lower after recent earnings while sector focus stays o AD HOC NEWS Thu, 04 Jun 2026 15:01:45 GMT
• behavioral patterns of gmab and institutional flows Stock Traders Daily Thu, 04 Jun 2026 07:00:00 GMT
• genmab a/s stock (dk0010272202): shares under pressure on nasdaq copenhagen amid oncology competitio AD HOC NEWS Wed, 03 Jun 2026 18:32:52 GMT
• genmab a/s stock (dk0010272202): shares under pressure after competitor data weigh on danish biotech AD HOC NEWS Tue, 02 Jun 2026 19:36:55 GMT
• genmab a/s stock (dk0010272202): copenhagen shares weaken as investors weigh outlook after updated a AD HOC NEWS Mon, 01 Jun 2026 19:55:16 GMT
• genmab a/s (gmab) stock analysis: a 39.83% potential upside in the biotech sector DirectorsTalk Interviews Mon, 01 Jun 2026 09:17:45 GMT
• genmab a/ s stock (dk0010272202): board share sale keeps focus on denmark AD HOC NEWS Sat, 30 May 2026 13:58:45 GMT
• transactions with shares and linked securities in genmab a/s made by managerial employees and their closely associated persons The Manila Times Sat, 30 May 2026 07:00:00 GMT
• genmab discloses share transactions by managerial employees and associates under market abuse regulation. Pluang Fri, 29 May 2026 21:34:30 GMT
• genmab a/s stock (dk0010272202): nasdaq copenhagen shares little changed after recent cancer drug an AD HOC NEWS Fri, 29 May 2026 16:44:58 GMT
• Genmab (Nasdaq: GMAB) director sells 526 shares on NASDAQ Copenhagen Stock Titan Fri, 29 May 2026 07:00:00 GMT
• transactions with shares and linked securities in genmab a/s made by managerial employees and their closely associated persons Yahoo Finance Fri, 29 May 2026 07:00:00 GMT
• truist assumes genmab stock coverage with buy rating on pipeline Investing.com Wed, 27 May 2026 07:00:00 GMT
• genmab a/s stock (dk0010272202): antibody specialist with strong oncology focus and us partnerships AD HOC NEWS Tue, 26 May 2026 12:27:58 GMT
• genmab a/ s stock (dk0010272202): earnings momentum and antibody pipeline in focus AD HOC NEWS Tue, 26 May 2026 10:01:56 GMT
• Genmab A/S (GMAB) Investor Outlook: 39.73% Potential Upside Beckons Amid Strong Revenue Growth DirectorsTalk Interviews Mon, 25 May 2026 07:00:00 GMT
• genmab stock (dk0010272202): new catalyst keeps investor focus on antibody pipeline AD HOC NEWS Sun, 24 May 2026 14:59:43 GMT
• (gmab) movement within algorithmic entry frameworks Stock Traders Daily Sun, 24 May 2026 07:00:00 GMT
• gmab stock price, quote & chart | genmab a/s -sp adr (nasdaq:gmab) ChartMill Fri, 22 May 2026 07:00:00 GMT
• genmab a/s stock (dk0010272202): cancer drug specialist updates outlook after recent earnings AD HOC NEWS Thu, 21 May 2026 10:05:56 GMT
• Genmab to Highlight Advances Across Its Oncology Portfolio at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting... Yahoo Finance Thu, 21 May 2026 07:00:00 GMT
• genmab to highlight advances across its oncology portfolio at the 2026 american society of clinical oncology (asco) annual meeting... Business Wire Wed, 20 May 2026 07:00:00 GMT
• genmab a/s stock (dk0010272202): antibody specialist updates outlook after first?quarter results AD HOC NEWS Wed, 20 May 2026 07:00:00 GMT
• gmab stock price, quote & chart | genmab a/s -sp adr (nasdaq:gmab) ChartMill Wed, 20 May 2026 07:00:00 GMT
• genmab a/s stock (dk0010272202): revenue growth and pipeline in focus after latest quarterly report AD HOC NEWS Wed, 20 May 2026 05:06:11 GMT
• t-cell engagers market to record us$ 58.04 billion by 2035., openPR.com Tue, 19 May 2026 13:01:32 GMT
• genmab a/s stock (dk0010272202): earnings momentum and oncology pipeline keep investors watching AD HOC NEWS Tue, 19 May 2026 00:21:40 GMT
• genmab a/s - american depositary shares (nq: gmab The Chronicle-Journal Mon, 18 May 2026 20:00:00 GMT
• genmab maintained at buy as bofa notes upcoming key catalysts marketscreener.com Mon, 18 May 2026 09:48:51 GMT
• genmab a/s (gmab) stock analysis: a 41.47% potential upside in the biotech sector DirectorsTalk Interviews Mon, 18 May 2026 07:00:00 GMT
• genmab a/s stock (dk0010272202): antibody specialist in focus after latest earnings and pipeline upd AD HOC NEWS Mon, 18 May 2026 07:00:00 GMT
• genmab a/s stock (dk0010272202): antibody specialist in focus after latest earnings and pipeline upd AD HOC NEWS Sun, 17 May 2026 22:27:41 GMT
• genmab (cpse:gmab) valuation check after recent share price softness and 24.6% undervaluation estimate Yahoo Finance Sun, 17 May 2026 00:19:00 GMT
• Genmab (CPSE:GMAB) Valuation Check After Recent Share Price Softness And 24.6% Undervaluation Estimate Yahoo Finance Sat, 16 May 2026 07:00:00 GMT
• orbis, allan gray amend holdings in genmab (gmab) reporting 5.5% stake Stock Titan Fri, 15 May 2026 07:00:00 GMT
• gmab stock price, quote & chart | genmab a/s -sp adr (nasdaq:gmab) ChartMill Fri, 15 May 2026 07:00:00 GMT
• there may be some bright spots in genmab's (cph:gmab) earnings simplywall.st Fri, 15 May 2026 05:28:12 GMT
• gmab stock price, quote & chart | genmab a/s -sp adr (nasdaq:gmab) ChartMill Thu, 14 May 2026 07:00:00 GMT
• genmab a/ s stock (dk0010272202): shares up 3.48% on employee warrant exercise AD HOC NEWS Wed, 13 May 2026 15:46:48 GMT
• genmab updates articles of association, expands capital and incentive authorizations TipRanks Wed, 13 May 2026 14:54:20 GMT
• morgan stanley maintains an “equal weight” rating on genmab a/s (gmab) Insider Monkey Wed, 13 May 2026 07:00:00 GMT
• [6-k] genmab a/s current report (foreign issuer) | gmab sec filing - form 6-k Stock Titan Wed, 13 May 2026 07:00:00 GMT
Genmab A/S(NASDAQ:GMAB) 
Genmab A/S, a biotechnology company, develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye d...
Website: http://www.genmab.com
Founded: 1999
Full Time Employees: 712
CEO: Jan G. J. van de Winkel
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends